New drugs only account for 8.5% of all drug spending in KOR
By Eo, Yun-Ho | translator Kim, Jung-Ju
23.10.04 10:47:39
가나다라
0
Chung-Ang University Professor Jong-Hyuk Lee presents ‘New Drug Expenditure Status Analysis’
Proportion spent by PE exemption and RSA drugs are also low, accounting for 0.3% and 2.7% of total drug expenditures, respectively
On the 4th, the Korean Research-based Pharmaceutical Industry Association (KRPIA) released the results of 'A study on the analysis and rationalization of drug expenditures for new drugs in Korea' conducted by Professor Jong-Hyuk Lee from Chung-Ang University’s College of Pharmacy.
Study results showed that the expenditures spent on new drugs from the national health insurance finances accounted for 8.5% of total drug costs and 2.1% of the total national health insurance medical costs. In particular, the financial impact made by new drugs on national health insurance finances was a
Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)